Susanne Vrtala, PhD Department of Pathophysiology Center for Physiology and Pathophysiology Medical University of Vienna, Austria Recombinant mite allergens.

Slides:



Advertisements
Similar presentations
Laboratory of Immunobiochemistry Site Visit
Advertisements

Markus Nilsson Dept. Of Computer Science and Engineering Mälardalen University Västerås, Sweden.
Joakim Dillner, M.D. Professor Department of Laboratory Medicine Karolinska Institutet Sweden Karolinska Institutet.
Allergen regulation in the future : what will be the place for recombinant allergens ? Jacqueline DAYAN-KENIGSBERG European Academy of Allergology and.
Allergenicity assessment of genetically modified organisms (GMOs )
Diagnostic approach to the allergic patient. Allergic conditions in Israel.
House dust mite (HDM) is a common allergen and reactivity is associated with asthma and atopic dermatitis. The development of these allergic diseases depends.
T-cell Immunoregulation and the Response to Immunotherapy Harold S. Nelson. MD Professor of Medicine National Jewish Health and University of Colorado.
Historical overview Pr G. Pauli Hôpitaux Universitaires de Strasbourg Bischenberg 21 septembre 2007.
IB Computer Science – Logic
Molecular allergology and immunotherapy
47 ANALYSIS OF THE ALLERGENIC COMPONENTS IN TRADITIONAL APPLE CULTIVARS BY SINGLE POINT HIGHEST INHIBITION ACHIEVABLE ASSAY (SPHIAa) FOR IgE Palazzo Paola,
Recent Developments in Allergy Diagnosis and Treatment
False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides.
Volume 11, Pages (September 2016)
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines 
OVEREXPRESSION OF TRUNCATED ARA H2
Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R
Identification of common allergenic structures in mugwort and ragweed pollen  Reinhold Hirschwehr, MDa, Claudia Heppner, MSca, Susanne Spitzauer, MDb,
Angel Vallverdú, BSc, Juan A. Asturias, PhD, M
Food Allergies: The Basics
The effects of dasatinib on IgE receptor–dependent activation and histamine release in human basophils by Michael Kneidinger, Uwe Schmidt, Uwe Rix, Karoline.
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy  Margarete Focke-Tejkl, PhD, Milena.
Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy  Raphaela.
Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule  Carine Metz-Favre, MD, Birgit Linhart, PhD, Margarete Focke-Tejkl, PhD,
Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2  Fatima D. Ferreira,
In-Depth Discussion of Key Data on Immunotherapy for Allergic Diseases
Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity  Jens Holm, PhD, Nicholas Willumsen,
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines 
Wayne County, Indiana THE INDIANA PREVENTION RESOURCE CENTER
Recombinant allergens: What does the future hold?
In vivo allergenic activity of a hypoallergenic mutant of the major fish allergen Cyp c 1 evaluated by means of skin testing  Nikolaos Douladiris, MD,
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel.
Component-Resolved Diagnosis (CRD) of Type I Allergy with Recombinant Grass and Tree Pollen Allergens by Skin Testing  Susanne Heiss, Rudolf Valenta 
Molecular characterization of dog albumin as a cross-reactive allergen
Allergen microarray detects high prevalence of asymptomatic IgE sensitizations to tropical pollen-derived carbohydrates  Clarissa R. Cabauatan, PhD, Christian.
Component resolution reveals additional major allergens in patients with honeybee venom allergy  Julian Köhler, MS, Simon Blank, PhD, Sabine Müller, MD,
Chronic cat allergen exposure induces a TH2 cell–dependent IgG4 response related to low sensitization  Amedee Renand, PhD, Luis D. Archila, MSc, John.
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms  Raffaela.
Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen:
Der p 11 Is a Major Allergen for House Dust Mite-Allergic Patients Suffering from Atopic Dermatitis  Srinita Banerjee, Yvonne Resch, Kuan-Wei Chen, Ines.
A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines  David Walgraffe, PhD, Christel Mattéotti, PhD, Mohamed el Bakkoury, PhD,
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis  Natalija Novak, MD,
Underestimation of house dust mite–specific IgE with extract-based ImmunoCAPs compared with molecular ImmunoCAPs  Huey-Jy Huang, MSc, Yvonne Resch-Marat,
Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R
Selection of house dust mite–allergic patients by molecular diagnosis may enhance success of specific immunotherapy  Kuan-Wei Chen, PhD, Petra Zieglmayer,
Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen  Sonia de Halleux, MSc, Enrico.
Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: Importance for allergenic activity  Sabine Flicker, PhD, Peter.
IMMUNOTHERAPY ON THE TREATMENT OF ASTHMA, RHINITIS, FOOD ALLERGY
Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children  Yvonne Resch, MSc, Sven Michel, MSc, Michael Kabesch, MD,
Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for.
Skin test evaluation of a novel peptide carrier–based vaccine, BM32, in grass pollen– allergic patients  Verena Niederberger, MD, Katharina Marth, MD,
Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life  Daniela.
This study/project is funded by/ supported by the National Institute for Health Research (NIHR) [name of NIHR programme (Grant Reference Number XXX)/name.
Mohamed H. Shamji, PhD, FAAAI, Stephen R. Durham, MD, FRCP 
A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy  Fatimah Kussebi, MD, Fariba Karamloo, PhD, Claudio Rhyner,
A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS  Katarzyna Niespodziana, MSc, Margarete Focke-Tejkl, PhD, Birgit.
Recombinant allergen-based IgE testing to distinguish bee and wasp allergy  Irene Mittermann, PhD, Mihaela Zidarn, MD, Mira Silar, PhD, Zora Markovic-Housley,
This study/project is funded by/ supported by the National Institute for Health Research (NIHR) [name of NIHR programme (Grant Reference Number XXX)/name.
Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly  Raffaela Campana, PhD, Susanne Vrtala,
A general strategy for the generation of hypoallergenic molecules for the immunotherapy of fish allergy  Ines Swoboda, PhD, Nadja Balic, Christoph Klug,
Cloning, expression, and clinical significance of the major allergen from ash pollen, Fra e 1  Rodrigo Barderas, BSc, Ashok Purohit, MD, Ioanna Papanikolaou,
False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides.
This study/project is funded by/ supported by the National Institute for Health Research (NIHR) [name of NIHR programme (Grant Reference Number XXX)/name.
Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy– treated mother  Sabine Flicker, PhD, Katharina Marth, MD, Heinz.
Exposure to a farming environment has allergen-specific protective effects on TH2- dependent isotype switching in response to common inhalants  Debra A.
Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding  Sven.
Mast cell–derived proteases control allergic inflammation through cleavage of IgE  Ingrid Rauter, PhD, Maria-Theresa Krauth, MD, Kerstin Westritschnig,
Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy  Teresa E. Twaroch, MSc, Margit Focke, PhD, Vera Civaj, Milena.
Fig. 1. Changes of CD63 basophil reactivity to house dust mite (HDM) allergens in patients with house dust mite immunotherapy, basophil reactivity to Dp.
Presentation transcript:

Susanne Vrtala, PhD Department of Pathophysiology Center for Physiology and Pathophysiology Medical University of Vienna, Austria Recombinant mite allergens for diagnosis and immunotherapy in mite allergic patients

Groups of mite allergens

Isolation and characterization of Der p allergens Baldo & Donovan, 1988

Expression and purification of the clone 30- derived allergen

Diagnosis of mite allergy - with mite extracts, which contain a mixture of allergenic and non-allergenic components - extracts are standardized for Der p 1 and Der p 2 - some other important allergens are underrepresented in mite extracts - extracts do not allow a component-specific diagnosis Development of new diagnostic concepts with recombinant mite allergens

IgE-reactivity profiles to Der p allergens

Recombinant mite allergens for immunotherapy Production of hypoallergenic derivatives of mite allergens with reduced allergenic activity Immunotherapy with mite extracts - No patient-tailored therapy is possible - sensitization to new allergens is possible - Induction of severe anaphylactic side effects is possible

Patient 1Patient 2Patient 3Patient 4mean Der p 2 (aa 1-53) Der p 2 (aa ) Der p 2 Hybrid Der p IgG Abs induced with rDer p 2 derivatives inhibit patients‘ IgE binding to Der p 2 wildtype

- Identification of new mite allergens - A combination of Der p 1 and Der p 2 allows diagnosis of almost all mite allergic patients - Production of hypoallergenic derivatives of Der p 2 with reduced allergenic activity and retained immunogenicity Summary

Medical University of Vienna, Department of Pathophysiology, Division of Immunopathology Rudolf Valenta Group Immunotechnology Margit Weghofer Kuan-Wei Chen Anne Casset Wayne Thomas Telethon Institute of Child Health Research, Perth University of Western Australia Friedrich Horak Department of Otorhinolaryngology Medical University of Vienna Peter Valent Division of Hematology and Hemostaseology Medical University of Vienna Walter Keller Institute of Chemistry Karl-Franzens University of Graz Gabrielle Pauli Hôpitaux Universitaires de Strasbourg Allergy Unit National Health Service, Rome Adriano Mari Marianne van Hage Karolinska Institutet, Stockholm This work was supported by grants F1803, F1805, F1809 and F1815 of the Austrian Science Fund.